Cefazolin Sodium Salt Powder, a potent antibiotic in the cephalosporin class, effectively fights various bacterial infections, particularly Gram-positive strains. It works by halting bacterial cell wall synthesis, leading to bacterial demise.
Transitioning to its properties, Cefazolin Sodium Salt Powder remains stable in acidic and basic conditions, suitable for different pharmaceutical formulations. This stability ensures its efficacy when taken orally or intravenously.
Additionally, its low toxicity and minimal side effects make Cefazolin Sodium Salt Powder a preferred choice in clinical settings. Its safety and effectiveness have led to widespread adoption in hospitals and healthcare facilities.
In research, Cefazolin Sodium Salt Powder serves as a selective agent in microbial culture media. Its ability to suppress Gram-positive bacterial growth while promoting Gram-negative strains aids in identifying specific bacteria.
In summary, Cefazolin Sodium Salt Powder’s potent antibacterial action, versatility in treating infections, stability in formulations, and low toxicity underscore its importance in medical treatment and research. Its effectiveness and safety make it a valuable tool in combating bacterial infections and advancing medical science.
Cat. Number | AS-2026 |
CAS Number | 27164-46-1 |
Additional CAS | 25953-19-9 (acid) |
MDL Number | MFCD00056883 |
Pubchem | 310269464 |
Molecular Weight | 476.49 g/mol |
Molecular Formula | C14H13N8NaO4S3 |
Storage Temperature | 4°C |
Form and Color | Powder to Crystal / White to off-white to yellow |
Purity (HPLC) | ≥ 98% |
Melting Point | 170 – 177 °C |
Water | ≤ 6% |
Synonym | Atirin / Azolin |